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Aim: Microembolization continues to be a major risk for patients undergoing carotid artery stenting
(CAS) of high-grade atherosclerotic carotid stenoses. Further insight into the characteristics and signif-
icance of these embolized particles was deemed necessary. We aimed to assess the size and composition
of debris captured by ﬁlters during CAS and to determine if this could be predicted using standard
imaging techniques.
Methods: 20 patients (10 symptomatic, 15 men, mean age 64.6 years) undergoing CAS for high-grade ICA
stenosis were recruited. All underwent pre-operative CT angiography and calcium scoring. All underwent
CAS using the same protocol. A ﬁlter-type embolic protection device (EPD) was used and retrieved post-
operatively and captured particles underwent analysis using a Scanning Electron Microscope (SEM) for
counting, sizing, and composition.
Results: Clinical. Debris was found on 100% of ﬁlters when analysed with SEM. There were non-signiﬁcant
trends for CAS in asymptomatic patients to produce a greater number of smaller, calciﬁed particles while
in symptomatic patients we observed larger, lipid-rich particles. When stratiﬁed according to pre-
operative calcium scores, ‘calcium-rich’ plaques produced signiﬁcantly greater numbers of emboli
captured on the EPD (p ¼ 0.02).
Conclusions: Filter-type EPDs collect debris of signiﬁcant quantity and size during the CAS procedure as
performed in our institution. The collected material was likely dislocated from the atherosclerotic plaque.
CT calcium scoring allows us to predict the nature of material captured by the EPD. These data may allow
the clinician to individualise care during CAS and thus reduce peri-operative risk.
Crown Copyright  2010 Published by Elsevier Ltd on behalf of Surgical Associates Ltd. All rights
reserved.1. Introduction
Carotid endarterectomy (CEA) has long been established as the
standard treatment for symptomatic atherosclerotic stenosis of the
internal carotid artery (ICA), although it does have an accepted
complication rate.1,2 The development of carotid angioplasty and
stenting (CAS) as aminimally invasive treatment has joined surgery
in centres with extensive experience and skilled intervention-
alists.3,4 The rationale for carotid revascularization, surgical or
endovascular, is to reduce the future risk of stroke. Unfortunately,
carotid revascularization itself poses a risk of stroke, and enormous.
. Brightwell).
010 Published by Elsevier Ltd on befforts have been made in reﬁning both surgical and endoluminal
techniques to reduce peri-procedural stroke risk.
The chance of ischaemic events due to peri-procedural micro-
embolization is still a threat to those patients undergoing CAS. The
advent of embolic protection devices (EPDs) was greeted with great
enthusiasm for reducing the embolic risk. Nevertheless, although
EPDs seem safe and effective, silent ischaemic lesions thought
secondary to distal embolisation have been identiﬁed on diffusion-
weighted imaging (DWI) by several authors.5e11
Themorphology of the atherosclerotic wall has been the focus of
general interest because it has been proved to have a pivotal role in
plaque vulnerability.12 The purpose of the current study was to
describe the method and results of the electron microscopic anal-
ysis of ﬁlter content in protected CAS of severe ICA stenosis and to
evaluate any correlation with pre-operative imaging using
computed tomography (CT) calcium scoring. It was felt importantehalf of Surgical Associates Ltd. All rights reserved.
Fig. 1. Scanning electron micrograph of an Embolic Protection Device used during
a CAS procedure in a patient with a symptomatic ICA stenosis.
Fig. 2. SEM of a platelet aggregation seen on an EPD. Note that the circular ‘window’ it
is adherent to is one of the pores that make up the ﬁlter; they have a diameter of only
100 mm.
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CAS procedures, and to gain further insight into the way that the
ﬁlter-type EPD employed by our institution works.
2. Methods
Ethical approval was granted by a Local Research Ethics Committee (LREC) prior
to this study commencing. Consecutive patients were given full verbal and written
information about the research project prior to giving their written consent. It is our
standard of care that all patients are reviewed pre-operatively by a neurologist and
discussed at a joint surgical and neurological meeting before consideration for
intervention.Symptomatic patients were deﬁned as those with clinical symptoms of
a cerebrovascular accident (CVA), transient ischaemic attack (TIA) or amaurosis
fugax occurring within the last six months.
Patients who had smoked or who were currently smoking were considered in
the smoking group. Those that were receiving drugs for control of hypertension
were considered to be hypertensive.Patients with insulin-dependent and tablet-
controlled diabetes were placed into the diabetic group. Those with a family history
of vascular disease were considered to be patients with a 1st or 2nd degree relative
that suffered a stroke or coronary artery disease below the age of 65.
Details of ischaemic heart disease (IHD) were obtained. Patients with a history of
angina, myocardial infarction, coronary endoluminal intervention and coronary
artery bypass graft (CABG) were considered to have a history of IHD.
2.1. Pre-operative CTA and calcium scoring of target vessel
Patients had CT angiography (CTA) of their supra-aortic and intracranial vessels
prior to their revascularization procedure. This was performed routinely (on clinical
grounds) to further characterise the stenosis, to determine whether or not the
patients’ anatomy was suitable for CAS, to identify ‘tandem’ lesions, and to aid in
assessing whether those who might not be suitable for CAS would be at higher risk
of requiring intra-operative shunting (from assessment of the circle of Willis) during
their CEA.
Spiral CT angiography was performed with a 16 multi-detector row scanner
(Phillips MX8000, Phillips). A standard protocol was used: 120 kV, 210 mAs, 3 mm
section thickness, and 3 mm/s table feed. Volume acquisition typically covered the
region from the aortic arch to sella turcica with a scanning duration of 32e40 s.
Images were reconstructed every 1.5 mm, which resulted in 75e101 sections.
Patients were asked to avoid swallowing, but quiet breathing was allowed
throughout the examination.
Contrast material (Omnipaque 350, Amersham Health, UK) was injected intra-
venously with a power injector (Medtron Injektron CT2, Medizinische Systeme
GmbH, Germany) through a 14G intravenous cannula sited in the right antecubital
fossa. A volume of 120 mL at a rate of 3.5 mL/s was used. The mean delay between
the injection of the contrast material and the initiation of spiral CT scanning was 18 s
(range, 15e26 s).
In order to determine the degree of ICA stenosis data from the CT sections were
transferred to a satellite workstation for image processing. The axial CT images were
viewed for research purposes to determine the site of maximal carotid stenosis and
the presence and volume of calciﬁed plaques. Using the Maximal Intensity Projec-
tion (MIP) images, the narrowest point in the artery was measured and the stenosis
graded according to NASCET criteria.13
Calciﬁcation of the carotid plaquewas quantiﬁed using standardized CT software
implemented in the scanner, with calcium deﬁned as a radiation attenuating struc-
turewith a density ofmore than 130Hounsﬁeld units (HU) in an area of 0.5mm2. This
allowed the collection of 3 data points for each plaque. These comprised the area of
calcium (i.e. number of pixels covered by calciumwhenpresented in 2 dimensions) at
the site of maximum stenosis (CaMax), and the total area of calcium from all slices
within theplaque (CaTotal). The calciumscore (CaScore)was calculated as theproductof
the lesion areaand the cofactor1e4 (cofactor 1,130e199HU; cofactor2, 200e299HU,
cofactor 3, 300e399HU, cofactor 4 400HU) at themaximum thickness of the lesion
being measured.
For subsequent analyses it was decided that values for CaScore would be used for
three reasons; ﬁrstly because this ﬁgure correlates well with CaMax and CaTotal,
secondly because thewhole plaque (of which CaMax is the best measure) was subject
to intervention, and thirdly for simplicity and clarity in presenting the results. The
population were stratiﬁed into groups according to whether their CaScore was lower
or higher than the mean value (288.08). This allowed a more straightforward
analysis of whether pre-operative CT calcium scoring could predict the nature of
particles captured on the EPD.
2.2. Carotid angioplasty and stenting procedure
This has been described previously.14 Brieﬂy, CAS was performed under local
anaesthesia (20 mL 1% lidocaine) using access via the femoral artery in all cases. In
most cases an 8F guiding catheter was used, having previously cannulated the
external carotid artery. Heparin was administered to maintain an Activated Clotting
Time (ACT) of 250e300 s. Patients remained awake during the operation enablingactive, clinical monitoring of their neurological state. Routine physiological moni-
toring included pulse oximetry, electrocardiogram, and invasive blood pressure
measurement via the radial artery. The procedures were performed by a team
comprising a Consultant vascular surgeon, a Consultant radiologist, and a Consultant
interventional cardiologist. Use of an EPD and dedicated carotid stenting systemwas
universal e Carotid Wallstent and EZ FilterWire (Boston Scientiﬁc).
2.3. Retrieval of embolic protection device
At the end of each procedure the EPD/ﬁlter was retrieved from the patient as per
themanufacturer’s instructions. The ﬁlter was then cropped from its delivery system
and stored in 0.5% glutaraldehyde solution. The ﬁlters were then stored for batch
analysis using electron microscopy (EM).
2.4. Electron microscopy of the EPD
The ﬁlters were ﬁxed in 3% glutaraldehyde in cacodylate buffer (pH 7.2) and
dehydrated through a graded series of ethanol baths. The ﬁlters were then critical-
point dried from carbon dioxide, cut open to reveal the inner surface and mounted
on aluminium stubs with double-sided adhesive discs. The specimens were sputter-
coater with gold prior to examination in a Cambridge S-360 Scanning Electron
Microscope (SEM). Digital images from the SEMwere recorded using a Prism frame-
grabber (Fig. 1) and the emboli counted (total number), sized (100e500 mm,
500e1000 mm, and 1000þ mm) along the major (or longest) axis and analysed for
their composition (platelet aggregation/thrombus, calcium-rich material, amor-
phous material/lipid) by a single, experienced examiner blinded to the patients’
symptom status.
Table 1
Demographics of the symptomatic and asymptomatic study groups.
Variable Symptomatic Asymptomatic p value
(t-test)
N ¼ 10 % N ¼ 10 %
Age (years) 65.3  14.3 e 63.8  17.6 e ns
Male gender 8 80 7 70 ns
Ipsilateral stenosis (%)
Contralateral stenosis (%)
70.6
35.3
e
e
74.8
48.6
e
e
ns
ns
History of hypertension 9 90 9 90 ns
History of smoking 8 80 9 90 ns
History of dyslipidaemia 9 90 8 80 ns
History of diabetes
mellitus (IDDM or NIDDM)
2 20 1 10 ns
History of IHD (Previous
angina/MI/CABG/PCI)
6 60 5 50 ns
Post-operative deﬁcit 0 0 1* 10 ns
* ¼ Ocular stroke.
Table 2
Overview of results for SEM of ﬁlter-type embolic protection devices used during
carotid artery stenting.
Pathological Feature Filters (n ¼ 20) %
Macroscopic presence of debris 17 85
Symptomatic 9 90
Asymptomatic 8 90
Presence of debris on SEM 20 100
Mean number of particles per ﬁlter
Symptomatic 15.8 e
Asymptomatic 9.8 e
Filters with particles 100e500 mm 20 100
Filters with particles 500e1000 mm 16 80
Symptomatic 9 90
Asymptomatic 7 70
Filters with particles >1000 mm 3 15
Symptomatic 2 20
Asymptomatic 1 10
Mean size of particles (mm) 203.05  348.3 e
Symptomatic 274.8  574 e
Asymptomatic 131.3  158 e
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examiner to observemany hundreds/thousands of very small particles which would
have been prohibitive in terms of time, and questionable in terms of clinical
signiﬁcance (Fig. 2).2.5. Statistical analysis
Continuous variables were expressed as mean  SD. P-values  0.05 were
considered statistically signiﬁcant. Comparisons of demographics, risk factors and
comorbidity data between treatmentgroupsweremadeusing the t-test. Analysiswas
conducted by using the statistical software SPSS version 15.0 for Windows (SPSS Inc,
Chicago, IL, USA).3. Results
20 patients undergoing elective procedures were entered into
this study (Symptomatic ¼ 10, Asymptomatic ¼ 10). The demo-
graphics of each group are shown in Table 1.
One asymptomatic patient (5%) suffered a post-operative ocular
strokee this was conﬁrmed by neurological and ophthalmic review
and was permanent.
The only (non-signiﬁcant) difference of note between the study
groups are ﬁrstly the tendency to intervene on more severe ICA
stenoses if the patient is asymptomatic (Fig. 3 - there is no evidence
yet to support CAS in this group).Fig. 3. A comparison of the degree of ICA stenosis (measured using NASCET criteria on
CTA) between each study group.3.1. Electron microscopy
SEM was attempted and successful in 100% of all cases. A
summary of the pathological data is presented in Table 2.
The ﬁrst observation to be analysed was of the total number of
emboli captured by the EPD, as assessed using the electron
microscope. There was a tendency for CAS in asymptomatic
patients to produce more emboli, although this did not reach
statistical signiﬁcance (Fig. 4).
When the data are further stratiﬁed according to trapped particle
size, there was a non-signiﬁcant trend for CAS in the symptomatic
patient to produce more particles that measured >500 mm. It was
also shown, however, that CAS in the asymptomatic patients
produced signiﬁcantly more particles that measured<500 mm than
the same in symptomatic patients (Fig. 5a and b).
Themain constituent of each of the particles seen on the retrieved
EPD was then assessed using the SEM (Fig. 6). In cases where the
particle was heterogeneous in consistency, that part thought to
make up >50% by volume was listed as the main particle type.
A signiﬁcant trend for CAS in asymptomatic patients to cause
calcium-rich particles to be trapped was noted (8 vs 2; p < 0.05) as
was a tendency for the same in symptomatic patients to cause the
production of lipid-rich particles (1.2 vs 5.2; p < 0.05). There were
no statistically signiﬁcant differences in the number of platelet
aggregate/thrombus-type particles seen.Fig. 4. Differences in total number of captured emboli according to symptom status of
the patient.
Fig. 5. a: Number and size of captured particles produced during CAS procedures in
symptomatic and asymptomatic patients as assessed with SEM. b: CAS in asymp-
tomatic patients allowed the EPD to capture signiﬁcantly more particles sized less than
500 mm as assessed with SEM.
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It was noted that those plaques identiﬁed as ‘high density’ with
CT calcium scoring produced signiﬁcantly greater numbers of
emboli captured on the EPD (p ¼ 0.02), that these were more likely
to be approximately 500 mm in size, and of an increased likelihood
that they consisted of calcium-rich material (p ¼ ns). These results
are displayed graphically in Fig. 7aec.Fig. 6. Comparison of the particle types trapped by the ﬁlter-type EPD according to the
symptom status of the patient.4. Discussion
This study shows that ﬁlter-type EPDs can capture particulate
emboli released during CAS (stent placement and EPD retrieval
phases only) but not those before ﬁlter placement or after its
retrieval; these microemboli can contribute to increase peri-
procedural risk and should be taken into account when consideringc
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Fig. 7. a: Plaques identiﬁed with a ‘high’ calcium score produced signiﬁcantly more
emboli. b: There was a trend for highly calciﬁed plaques to produce smaller particles.
c: Such captured particles were more likely to be calcium-rich.
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ﬁlter protection during ex vivo experiments.15,16 Debris was
captured in 100% of procedures when assessed using SEM which
agrees with the results of a similar study recently published,17
compared with 83.7% and 77% impreviously published studies
that performed histological analysis of captured particulate
debris,18,19 and 60.5% when visually inspecting the used EPD.20 The
way that CAS is performed at our institution universally produces
particles measuring 100e500 mm, and with the cerebral microcir-
culation encompassing vessels with a diameter of <300 mm it is
extremely likely that signiﬁcant cerebral microembolization was
prevented.21 It cannot, however, be excluded that some of the
retrieved thrombus/platelet material could have been locally
produced inside the EPD. As for the amorphous material, the only
feasible source was material dislodged from the target lesion. The
importance of calcium was highlighted by the signiﬁcant differ-
ences seen in the composition of particles released from asymp-
tomatic versus symptomatic plaques. This observation and its
implications require further exploration.
One can assume that not all of the capturedparticles, if allowed to
embolise to the brain, would have had clinical consequences.
Though the aimof someof thepreviouslydescribed studieshas been
to examine this, the signiﬁcance of clinically silent embolisation
during CEA and CAS is yet to be fully established. Certainly emboli
can potentially trigger platelet aggregation and may thus amplify
microvascular obstruction21 and a shower of microemboli could
cause similar effects. Furthermore, vasoactive substances contained
within plaque or thrombus fragments can cause intense, prolonged
vasospasm and subsequent brain infarction.22
An interestingﬁndingwasnotedwhen the resultsofpre-operative
imaging with CT calcium scores were correlated with the particulate
matter captured on a ﬁlter-type EPD during CAS: dense/calciﬁed
plaques produced greater numbers of small, calcium-rich debris
which, as a result of basic scientiﬁc experiment, are knowntobemore
injurious to the brain than ﬁbrous emboli.23,24 This observation may
help to explainwhy the group of patientswith asymptomatic plaques
in the SAPPHIRE study had worse outcomes than those who were
symptomatic; many of such patients underwent CAS without the
beneﬁt of an EPD, thereby resulting in greater numbers of small,
calciﬁed particles impacting on the brain parenchyma.4
As a logical conclusion to this data, it must be suggested that
patients with calciﬁed lesions (detected with either duplex or CT)
demand the best possible cerebral protection; in such cases a ﬁlter-
type EPD may not be the most appropriate since it may allow some
emboli to pass through its pores, or lead to increased incidence of
emboli as measured using transcranial Doppler.25,26 Flow-reversal
or balloon occlusion devices are an alternative, but the potential
beneﬁts of emboli reduction must be compared with the potential
risks of cerebral malperfusion.
This main ﬁnding of greater numbers of calciﬁed particles
captured from asymptomatic plaques is in contradiction to
a previously published study of electron microscopy of 20 retrieved
EPDs.17 The reasons for the different observation are likely mani-
fold. Malik et al. used a variety of ﬁlters and stents during the CAS
procedures and used Grey Scale Median (GSM) to assess the plaque
structure as opposed to CTA and calcium scoring. A different peri-
operative antiplatelet regimen was also employed which may have
changed the number of platelet aggregates seen in each study and
therefore skewed the results.
Despite the routine use of a ﬁlter-type EPD, we maintain that
embolisation during CAS (as performed at our institution) is inev-
itable. Without performing a post mortem examination in these
cases it is impossible to suggest the size and nature of those emboli
that defeat this variety of EPD. Some may argue it is futile to make
an analysis of the captured particles when trying to determine theireffects, since by their presence in the ﬁlter they are asymptomatic
emboli. Such data, however, may allow the clinician to extrapolate
the peri-operative risks of embolisation for individual cases prior to
CAS and thereby provide a personalised treatment (i.e. stent,
delivery device, EPD, anticoagulation regimen, open surgery) to
reduce these - especially in patients with calciﬁed plaques as
determined by pre-operative CT calcium scoring.
5. Conclusion
This study demonstrates that ﬁlter-type EPDs collect debris of
signiﬁcant quantity and size during the CAS procedure. Analysis
with scanning electron microscopy showed that the collected
material is most probably dislocated from the atherosclerotic pla-
que. Protection devices therefore have the potential to reduce
neurological complications caused by emboli measuring greater
than the size of the ﬁlter pores (typically 100 mm) during the
treatment of carotid artery stenosis.
Conﬂict of interest
Nil declared.
Funding
Mr RE Brightwell’s salary and some running costs are paid by
a joint Research Fellowship awarded by The Royal College of
Surgeons of England and The Stroke Association UK. These sponsors
had no role in the study design, in the collection, analysis and
interpretation of data; in the writing of the manuscript; and in the
decision to submit the manuscript for publication.
Ethical approval
Ethical approval for this study was granted by a Local Research
Ethics Committee (LREC).
References
1. Theodotou B, Mahaley Jr MS. Injury to the peripheral cranial nerves during
carotid endarterectomy. Stroke 1985;16:894e5.
2. Astor FC, Santilli P, Tucker HM. Incidence of cranial nerve dysfunction following
carotid endarterectomy. Head Neck Surg 1983;6:660e3.
3. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et al. Protected
carotid artery stenting versus endarterectomy in high-risk patients. N Engl J
Med 2004;351:1493e501.
4. Endovascular versus surgical treatment in patients with carotid stenosis in the
Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS):
a randomised trial. Lancet 2001;357:1729e37.
5. Schlüter M, Tübler T, Steffens JC, Mathey DG, Schofer J. Focal ischemia of the
brain after neuroprotected carotid artery stenting. J Am Coll Cardiol
2003;42:1007e13.
6. Zwenneke H, Ouhlous M, Hendriks J, van Sambeek MRHM, Veenland JF,
Koudstaal PJ, et al. Cerebral ischemia after carotid intervention. J Endovasc Ther
2004;11:251e7.
7. Jaeger H, Mathias K, Drescher R. Clinical results of cerebral protection with
a ﬁlter device during stent implantation of the carotid artery. Cardiovasc
Intervent Radiol 2001;24:249e56.
8. Jaeger H, Mathias K, Hauth E, Drescher R, Gissler HM, Hennigs S, et al. Cerebral
ischemia detected with diffusion weighted MR imaging after stent implanta-
tion in the carotid artery. Am J Neuroradiol 2002;23:200e7.
9. Lövblad KO, Plüschke W, Remonda L. Diffusion-weighted MRI for monitoring
neurovascular interventions. Neuroradiology 2000;42:134e8.
10. Poppert H, Wolf O, Resch M, Theiss W, Schmidt-Thieme T, von Einsiedel HG,
et al. Differences in number, size and location of intracranial microembolic
lesions after surgical versus endovascular treatment without protection device
of carotid artery stenosis. J Neurol 2004;251:1198e203.
11. van Heesewijk HP, Vos JA, Louwerse ES, van den Berg J, Overtoom TTC,
Ernst SMPG, et al. New brain lesions at MR imaging after carotid angioplasty
and stent placement. Radiology 2002;224:361e5.
12. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary
artery disease and the acute coronary syndromes. N Engl J Med
1992;326:242e50.
13. Beneﬁcial effect of carotid endarterectomy in symptomatic patients with high-
grade carotid stenosis: North American Symptomatic Carotid Endarterectomy
Trial Collaboration. N Engl J Med 1991;325:445e53.
14. Brightwell RE, Sherwood RA, Athanasiou T, Hamady M, Cheshire NJ. The
neurological morbidity of carotid revascularisation: using markers of cellular
R.E. Brightwell et al. / International Journal of Surgery 9 (2011) 177e182182brain injury to compare CEA and CAS. Eur J Vasc Endovasc Surg 2007 Nov;34
(5):552e60.
15. Ohki T, Marin ML, Lyon RT. Ex vivo human carotid artery bifurcation stenting:
correlation of lesion characteristics with embolic potential. J Vasc Surg
1998;27:463e71.
16. Bicknell CD, Cheshire NJ. The relationship between carotid atherosclerotic
plaque morphology and the embolic risk during endovascular therapy. Eur J
Vasc Endovasc Surg 2003;26:17e21.
17. Malik RK, Landis GS, Sundick S, Cayne N, Marin M, Faries PL. Predicting embolic
potential during carotid angioplasty and stenting: analysis of captured
particulate debris, ultrasound characteristics, and prior carotid endarterec-
tomy. J Vasc Surg 2010;51:317e22.
18. Angelini A, Reimers B, Della Barbera M, Saccà S, Pasquetto G, Cernetti C, et al.
Cerebral protection during carotid artery stenting: collection and histopatho-
logical analysis of embolized debris. Stroke 2002;33:456e61.
19. DeRubertis BG, Chaer RA, Gordon R, Bell H, Hynecek RL, Pieracci FM, et al.
Determining the quantity and character of carotid artery embolic debris by
electron microscopy and energy dispersive spectroscopy. J Vasc Surg
2007;45:716e25.20. Sprouse LR, Peeters P, Bosiers M. The capture of visible debris by distal cerebral
protections ﬁlters during carotid artery stenting: is it predictable? J Vasc Surg
2005;41:950e5.
21. Topol EJ, Yadav JS. Recognition of the importance of embolization in athero-
sclerotic vascular disease. Circulation 2000;101:570e80.
22. Williams DO. Carotid ﬁlters: new additions to the interventionist’s toolbox.
Circulation 2001;104:2e3.
23. Rapp JH, Pan XM, Sharp FR, Shah DM, Wille GA, Velez PM, et al. Atheroemboli
to the brain: size threshold for causing acute neuronal cell death. J Vasc Surg
2000;32:68e76.
24. Rapp JH, Pan XM, Yu B, Swanson RA, Higashida RT, Simpson P, et al. Cerebral
ischemia and infarction from atheroemboli <100 mm in Size. Stroke
2003;34:1976e80.
25. Vos JA, van den Berg JC, Ernst SM, Suttorp MJ, Overtoom TT, Mauser HW, et al.
Carotid angioplasty and stent placement: comparison of transcranial Doppler US
data and clinical outcomewithandwithoutﬁltering cerebral protectiondevices in
509 patients. Radiology 2005;234:493e9.
26. Macdonald S. Is there any evidence that cerebral protection is beneﬁcial?
experimental data. J Cardiovasc Surg (Torino) 2006 Apr;47(2):127e36.
